news
July 31 2014
Expanded Data on Disability and Cognitive Improvements in Phase II Study of Synthetic Biologics' Trimesta™ in Multiple Sclerosis to be Presented at 2014 Joint ACTRIMS-ECTRIMS Meeting
July 30 2014
BioLineRx to Report Second Quarter 2014 Results on August 6, 2014
July 29 2014
Advaxis and the University of Pennsylvania Restructure Their Exclusive License Agreement
|
|
events
|
|
spotlight
|
